Literature DB >> 22658486

Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.

Lisia Esper1, Danilo Roman-Campos, Aline Lara, Fatima Brant, Luisa L Castro, Andreia Barroso, Ronan Ricardo S Araujo, Leda Q Vieira, Shankar Mukherjee, Eneas Ricardo M Gomes, Nazareth N Rocha, Isalira P R Ramos, Michael P Lisanti, Camila F Campos, Rosa M E Arantes, Silvia Guatimosim, Louis M Weiss, Jader Santos Cruz, Herbert B Tanowitz, Mauro M Teixeira, Fabiana S Machado.   

Abstract

Infection with Trypanosoma cruzi induces inflammation, which limits parasite proliferation but may result in chagasic heart disease. Suppressor of cytokine signaling 2 (SOCS2) is a regulator of immune responses and may therefore participate in the pathogenesis of T. cruzi infection. SOCS2 is expressed during T. cruzi infection, and its expression is partially reduced in infected 5-lipoxygenase-deficient [knockout (KO)] mice. In SOCS2 KO mice, there was a reduction in both parasitemia and the expression of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), IL-6, IL-10, SOCS1, and SOCS3 in the spleen. Expression of IFN-γ, TNF-α, SOCS1, and SOCS3 was also reduced in the hearts of infected SOCS2 KO mice. There was an increase in the generation and expansion of T regulatory (Treg) cells and a decrease in the number of memory cells in T. cruzi-infected SOCS2 KO mice. Levels of lipoxinA(4) (LXA(4)) increased in these mice. Echocardiography studies demonstrated an impairment of cardiac function in T. cruzi-infected SOCS2 KO mice. There were also changes in calcium handling and in action potential waveforms, and reduced outward potassium currents in isolated cardiac myocytes. Our data suggest that reductions of inflammation and parasitemia in infected SOCS2-deficient mice may be secondary to the increases in Treg cells and LXA(4) levels. This occurs at the cost of greater infection-associated heart dysfunction, highlighting the relevance of balanced inflammatory and immune responses in preventing severe T. cruzi-induced disease.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658486      PMCID: PMC3388166          DOI: 10.1016/j.ajpath.2012.03.042

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.

Authors:  R R Tonelli; A C Torrecilhas; J F Jacysyn; M A Juliano; W Colli; M J M Alves
Journal:  Parasitology       Date:  2010-11-02       Impact factor: 3.234

2.  5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection.

Authors:  Wander R Pavanelli; Fredy R S Gutierrez; Flávia S Mariano; Cibele M Prado; Beatriz Rossetti Ferreira; Mauro Martins Teixeira; Cláudio Canetti; Marcos A Rossi; Fernando Q Cunha; João S Silva
Journal:  Microbes Infect       Date:  2010-04-08       Impact factor: 2.700

Review 3.  Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses.

Authors:  I C Almeida; R T Gazzinelli
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

4.  DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.

Authors:  L K Shoda; K A Kegerreis; C E Suarez; I Roditi; R S Corral; G M Bertot; J Norimine; W C Brown
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Gigantism in mice lacking suppressor of cytokine signalling-2.

Authors:  D Metcalf; C J Greenhalgh; E Viney; T A Willson; R Starr; N A Nicola; D J Hilton; W S Alexander
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

6.  Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

Authors:  F S Machado; G A Martins; J C Aliberti; F L Mestriner; F Q Cunha; J S Silva
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

Review 7.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

8.  Molecular identification of a TTX-sensitive Ca(2+) current.

Authors:  S Guatimosim; E A Sobie; J dos Santos Cruz; L A Martin; W J Lederer
Journal:  Am J Physiol Cell Physiol       Date:  2001-05       Impact factor: 4.249

Review 9.  Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?

Authors:  Renato Sathler-Avelar; Danielle Marquete Vitelli-Avelar; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

10.  SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses.

Authors:  Camille A Knosp; Helen P Carroll; Joanne Elliott; Sean P Saunders; Hendrik J Nel; Sylvie Amu; Joanne C Pratt; Shaun Spence; Emma Doran; Nicola Cooke; Ruaidhri Jackson; Jonathan Swift; Denise C Fitzgerald; Liam G Heaney; Padraic G Fallon; Adrien Kissenpfennig; James A Johnston
Journal:  J Exp Med       Date:  2011-06-06       Impact factor: 14.307

View more
  21 in total

Review 1.  Dendritic cells and parasites: from recognition and activation to immune response instruction.

Authors:  Claudia Cristina Motran; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Semin Immunopathol       Date:  2016-09-01       Impact factor: 9.623

2.  The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.

Authors:  Andréia Barroso; Melisa Gualdrón-López; Lísia Esper; Fátima Brant; Ronan R S Araújo; Matheus B H Carneiro; Thiago V Ávila; Danielle G Souza; Leda Q Vieira; Milene A Rachid; Herbert B Tanowitz; Mauro M Teixeira; Fabiana S Machado
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 3.  A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure.

Authors:  Yesica Abril Botello-Flores; Martha Yocupicio-Monroy; Norma Balderrábano-Saucedo; Alejandra Contreras-Ramos
Journal:  Mol Biol Rep       Date:  2022-04-01       Impact factor: 2.742

4.  Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Authors:  Fatima Brant; Aline S Miranda; Lisia Esper; David Henrique Rodrigues; Lucas Miranda Kangussu; Daniella Bonaventura; Frederico Marianetti Soriani; Vanessa Pinho; Danielle G Souza; Milene Alvarenga Rachid; Louis M Weiss; Herbert B Tanowitz; Mauro Martins Teixeira; Antônio Lucio Teixeira; Fabiana Simão Machado
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

Review 5.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 6.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

Review 7.  Trypanosoma cruzi parasites fight for control of the JAK-STAT pathway by disarming their host.

Authors:  Philipp Stahl; Ralph T Schwarz; Françoise Debierre-Grockiego; Thomas Meyer
Journal:  JAKSTAT       Date:  2015-02-03

Review 8.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

9.  Cardiomyocyte dysfunction during the chronic phase of Chagas disease.

Authors:  Danilo Roman-Campos; Policarpo Sales-Júnior; Hugo Leonardo Duarte; Eneas Ricardo Gomes; Silvia Guatimosim; Catherine Ropert; Ricardo Tostes Gazzinelli; Jader Santos Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

10.  IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.

Authors:  Eugenia Hovsepian; Federico Penas; Sofía Siffo; Gerardo A Mirkin; Nora B Goren
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.